Cis-5-tert-butyl 8a-ethyl octahydropyrrolo[3,4-c]azepine-5,8a(1H)-dicarboxylate

Catalog No. :
ACMETO353
CAS No. :
1330766-26-1
Molecular Formula :
C16H28N2O4
Molecular Weight :
312.41

IUPAC Name:5-(tert-butyl) 8a-ethyl (3aS,8aR)-hexahydropyrrolo[3,4-c]azepine-5,8a(1H,6H)-dicarboxylate

Cis-5-tert-butyl 8a-ethyl octahydropyrrolo[3,4-c]azepine-5,8a(1H)-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$6030.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCis-5-tert-butyl 8a-ethyl octahydropyrrolo[3,4-c]azepine-5,8a(1H)-dicarboxylate
IUPAC Name5-(tert-butyl) 8a-ethyl (3aS,8aR)-hexahydropyrrolo[3,4-c]azepine-5,8a(1H,6H)-dicarboxylate
Molecular FormulaC16H28N2O4
Molecular Weight312.41
SMILESCCOC(=O)[C@]12CCCN(C(=O)OC(C)(C)C)C[C@@H]1CNC2
InChI KeyZLOQUTOOZGRYOE-LRDDRELGSA-N
SynonymCis-5-Tert-Butyl 8A-Ethyl Octahydropyrrolo[3,4-C]Azepine-5,8A(1H)-Dicarboxylate;Cis-5-Tert-Butyl 8A-Ethyl Octahydropyrrolo[3,4-C]Azepine-5,8A(1H)-Dicarboxylate(WX110939);Pyrrolo[3,4-c]azepine-5,8a(1H,4H)-dicarboxylic acid, hexahydro-, 5-(1,1-dimethylethyl) 8a-ethyl ester, (3aR,8aR)-rel-
CAS No.1330766-26-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMETO353 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMETO353 route product structure diagram
    ACMETO3531330766-26-1
Inquiry

2. ACMETO353 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMETO353 route product structure diagram
    ACMETO3531330766-26-1
Inquiry

Comments (0)